Antiviral Therapy (CMV/HIV)
"May Life-Long Anti-Cytomegalovirus Treatment Slow Clinical Progression of AIDS?."
Published in AIDS Weekly, May 5th, 1997
According to an abstract submitted by the authors to the Ninth Symposium on HIV Infection entitled From Virology ... To Therapy, held March 6-8, 1997, in Toulon, France, "Objective: To evaluate the effects of long-term suppressive anti-Cytomegalovirus (CMV) antiviral treatment on disease progression and survival of patients (p) with AIDS and CMV retinitis. Patients and Methods: Six AIDS p out of 522 followed by our Department since 1985 (3 males and 3 females, aged 28 to 45 years), were treated continuatively with ganciclovir and/or foscarnet at currently recommended dosages for both acute-phase and maintenance therapy of CMV retinitis, for a time longer than 15 months...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (1997-05-05)
More Articles from AIDS Weekly
- AIDS Therapies
HIV Related Psychotherapy - AIDS Therapies
HIV Replication In Living Cells Blocked Using Eukarion Antibody Lipidation - AIDS Therapies
Structure Analysis Could Lead To Delavirdine Improvement - AIDS Therapies (CGP64222)
First Antiviral To Selectively Block Protein/RNA Interaction - Dental Vaccines
Cavity-Fighting Vaccine Goes to Work in Gut - AIDS Research
Dr. Luc Montagnier Initiating AIDS Research Centers in South Africa and New York - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
